You just read:

Flagship Pioneering Unveils Kintai Therapeutics and Appoints Pharmaceutical Drug Developer Paul-Peter Tak, M.D., Ph.D., as Chief Executive Officer

News provided by

Flagship Pioneering

Apr 16, 2019, 07:00 ET